New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVS’s income statement to Excel — free account
Novartis AG
NVSHealthcare Drug Manufacturers General
Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.
- Revenue
- +4.67%
- EPS
- −68.8%
- Free cash flow
- −17.8%
- Total debt
- +53.9%
Quarter to September 2026, against a year earlier
152.04
0.83
+0.55%
Follow NVS
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
It owes $37.4B more in debt than it holds in cash and short-term investments. Debt has risen from $33.5B to $46.3B since Q4 FY25. Shareholders’ equity is 32.1% of the balance sheet. What is a balance sheet?
Owns
$88.4BLong-term assets
$19.8BOther short-term assets
$9.0BCash & short-term investments
Funded by
$37.6BShareholders’ equity
$33.2BOther liabilities
$46.3BDebt
Debt is 39.6% of the total; shareholders’ equity 32.1%.
Net debt rose from 20% of assets to 32% since Q4 FY25.
Net debt ÷ assets (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Total assets | $110.9B | $118.5B | $122.0B | $117.1B |
| Net debt (debt less cash) | $21.9B | $38.1B | $39.4B | $37.4B |
| Net debt ÷ assets (right axis) | 19.8% | 32.1% | 32.3% | 31.9% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
8,975.00 | 7,690.00 | 6,977.00 | 11,590.00 |
+8 more quarters Free account |
Receivables |
9,963.00 | 9,854.00 | 9,602.00 | 9,142.00 | |
Inventory |
6,104.00 | 6,220.00 | 6,286.00 | 6,269.00 | |
Other current assets |
3,705.00 | 3,587.00 | 3,742.00 | 3,459.00 | |
Total current assets |
28,747.00 | 27,351.00 | 26,607.00 | 30,460.00 | |
Property, Plant, Equpment (Net) |
10,622.00 | 10,685.00 | 10,654.00 | 10,782.00 | |
Long-Term Investments |
63.00 | 2,371.00 | 100.00 | 98.00 | |
Goodwill and Intangible Assets (Total) |
67,002.00 | 68,841.00 | 67,028.00 | 54,978.00 | |
Long Term Assets (Tax, Deferred) |
5,346.00 | 5,277.00 | 5,247.00 | 5,438.00 | |
Long-term assets (Other) |
3,720.00 | 5,926.00 | 7,312.00 | 7,623.00 | |
Total non-current assets |
88,402.00 | 94,682.00 | 91,925.00 | 80,489.00 | |
Total Assets |
117,149.00 | 122,033.00 | 118,532.00 | 110,949.00 | |
Accounts Payable |
4,243.00 | 4,258.00 | 4,322.00 | 4,456.00 | |
Current Part of Debt |
9,650.00 | 9,588.00 | 7,617.00 | 5,602.00 | |
Current Part of Taxes to Pay |
2,652.00 | 2,312.00 | 1,807.00 | 1,969.00 | |
Other current liabilities |
15,702.00 | 15,316.00 | 17,357.00 | 14,988.00 | |
Total current liabilities |
32,525.00 | 31,748.00 | 31,374.00 | 27,278.00 | |
Long Term Debt (Total) |
36,699.00 | 37,489.00 | 37,447.00 | 27,935.00 | |
Long Term Tax Liability (Deferred) |
4,397.00 | 5,292.00 | 5,104.00 | 3,397.00 | |
Non-current Liabilities (Other) |
4,281.00 | 3,895.00 | 4,017.00 | 4,133.00 | |
Total non-current liabilities |
47,060.00 | 48,339.00 | 48,231.00 | 37,122.00 | |
Total liabilities |
79,585.00 | 80,087.00 | 79,605.00 | 64,400.00 | |
Common Stock (Net) |
736.00 | 736.00 | 736.00 | 766.00 | |
Retained Earnings |
36,546.00 | 40,855.00 | 37,823.00 | 45,414.00 | |
Treasury Stock |
54.00 | 49.00 | 47.00 | 50.00 | |
Common Equity (Total) |
37,564.00 | 41,946.00 | 38,927.00 | 46,549.00 | |
Shareholders Equity (Total) |
37,564.00 | 41,946.00 | 38,927.00 | 46,549.00 | |
Shareholders Equity and Liabilities (Total) |
117,149.00 | 122,033.00 | 118,532.00 | 110,949.00 | |
Shares (Common) |
— | 1,900.70 | — | 1,908.15 | |
Shareholders Equity (Tangible) |
(29,438.00) | (26,895.00) | (28,101.00) | (8,429.00) | |
Net Debt |
37,374.00 | 39,387.00 | 38,087.00 | 21,947.00 | |
Total Debt |
46,349.00 | 47,077.00 | 45,064.00 | 33,537.00 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026